BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on ...

Organoids Market is Segmented by Type (Stem Cell Source, Tumor Cell Source), by Application (Biopharmaceutical Companies, Academics and Research Institutes, Hospital).

BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative ...

Researchers at Baylor College of Medicine and collaborating institutions have uncovered a key molecular player that is involved in lung repair and in ...

The Catholic Medical Center of Catholic University has taken a meaningful first step in the treatment of osteoarthritis.

Hayley Jankowski has been interested in biomedical research since her freshman year of high school. Now, the Rowan University ...

As, that fuels belly fat growth in middle age, offering a target for therapies to combat age-related obesity and disease.

Mesoblast Limited’s FDA-approved Ryoncil and advancing Revascor target major conditions like SR-aGVHD and heart failure. See ...

A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from ...